Precigen Inc (FRA:I5X)
€ 0.8505 0.017 (2.04%) Market Cap: 264.54 Mil Enterprise Value: 252.32 Mil PE Ratio: 0 PB Ratio: 5.71 GF Score: 45/100

Precigen Inc R&D Day Transcript

Jan 24, 2023 / 09:30PM GMT
Release Date Price: €1.98 (-1.37%)
Operator

Hello, and welcome to the Precigen Virtual R&D Day for PRGN 2012. At this time all participants are in listen-only mode (Operator Instructions) As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Steve Harasym. Please go ahead.

Steven Harasym
Precigen, Inc. - VP & Head of IR

Thank you, Kevin, and thank you to all joining us for this update call today. Before we begin, I'd remind everyone that today's call will make various forward-looking statements. Investors are cautioned that our forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results or outcomes to differ from those indicated by our forward-looking statements. Please read the safe harbor statements contained in this presentation as well as the risk factors contained in Precigen's most recent SEC filings for a more complete discussion on these risks and uncertainties.

Today, I am pleased to be joined by Dr. Helen Sabzevari, President and CEO of Precigen; and Dr. Clint

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot